3WOO
Crystal structure of the DAP BII hexapeptide complex I
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Detector technology | CCD |
Collection date | 2013-02-17 |
Detector | ADSC QUANTUM 270 |
Wavelength(s) | 0.98000 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 121.700, 121.700, 218.970 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 39.920 - 1.800 |
R-factor | 0.18441 |
Rwork | 0.182 |
R-free | 0.22436 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3woi |
RMSD bond length | 0.019 |
RMSD bond angle | 1.881 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.7.0032) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 40.000 |
High resolution limit [Å] | 1.800 |
Number of reflections | 143581 |
Completeness [%] | 99.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 9.5 | 293 | 18% PEG 8000, 20% Glycerol, 2mM ZnCl2, 80mM CHES, 2mM Angiotensin II, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K |